Representative computed tomography (CT) scans of the patient with NSCLC who had an uPR are presented in Fig. 5B. This patient was a 67-year-old man with stage IV KRAS+ adenocarcinoma who had received five prior lines of therapy in the metastatic setting. The gene discussed is KRAS; the disease is adenocarcinoma.